New COPD drug tozorakimab moves to Long-Term safety check

NCT ID NCT07566195

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 22, 2026 · Updated 7 times

Summary

This study is testing the long-term safety of a drug called tozorakimab in people with chronic obstructive pulmonary disease (COPD) who have had flare-ups in the past. About 82 participants who completed earlier studies will receive tozorakimab and be monitored for side effects. The goal is to see if the drug remains safe over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tozorakimab (a drug given as an injection)
What this could lead to: If successful, this could show that tozorakimab is safe for long-term use and help control COPD flare-ups.
What could go wrong: This is an open-label study with no placebo group, so results may be less reliable. It only includes people who already tolerated the drug in earlier trials, which may not reflect the broader COPD population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD

Contacts and locations

Locations

Research Site
RECRUITING

Aix-en-Provence, 13616, France
Research Site
RECRUITING

Brest, 29609, France
Research Site
WITHDRAWN

Colmar, 68024, France
Research Site
RECRUITING

Gleizé, 69400, France
Research Site
RECRUITING

Grenoble, 38043, France
Research Site
RECRUITING

Lyon, 69317, France
Research Site
RECRUITING

Marseille, 13015, France
Research Site
RECRUITING

Montpellier, 34295, France
Research Site
RECRUITING

Pessac, 33600, France
Research Site
RECRUITING

Pringy, 74374, France
Research Site
RECRUITING

Quimper, 29000, France
Research Site
RECRUITING

Saint-Herblain, 44800, France
Research Site
RECRUITING

Toulouse, 31000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.